|
US5273993A
|
|
Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
|
|
US5244907A
|
|
Carbocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents
|
|
US5236931A
|
|
2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
|
|
US5273972A
|
|
[(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
|
|
US5190953A
|
|
Heterocyclic carboxylic acid amides and esters of azabicyclic compounds as gastric prokinetic, antiemetic, anxiolytic and antiarrhythmic agents
|
|
US5183903A
|
|
Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
|
|
US5151418A
|
|
Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
|
|
US5183902A
|
|
Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
|
|
US5194446A
|
|
Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
|
|
US5206246A
|
|
Anxiolytic-R-n(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
|
|
US5192785A
|
|
Sulfamates as antiglaucoma agents
|
|
PH30230A
|
|
A locally administrable therapeutic composition for inflammatory disease
|
|
US5171753A
|
|
Derivatives of 2-amino-1-phenylethanol having antiulcer activity
|
|
US5140026A
|
|
N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as antiarrhythmic agents
|
|
US5106857A
|
|
N-(1-methyl-3-pyrrolidinyl)-1-(phenylmethyl)-1H-benzimidazol-2-amine and analogs as antiarrhythmic and muscle relaxing agents
|
|
US5137895A
|
|
3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols
|
|
US5130309A
|
|
Aryloxy and aryloxyalklazetidines as antiarrhythmic and anticonvulsant agents
|
|
US5057534A
|
|
3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects
|
|
US5114944A
|
|
2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects
|
|
US5162322A
|
|
Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones
|
